User profiles for Moses Kamya

Moses R Kamya

Makerere University College of Health Sciences, Infectious Diseases Research
Verified email at idrc-uganda.org
Cited by 25778

[HTML][HTML] HIV testing and treatment with the use of a community health approach in rural Africa

…, CR Cohen, E Bukusi, MR Kamya… - … England Journal of …, 2019 - Mass Medical Soc
Background Universal antiretroviral therapy (ART) with annual population testing and a
multidisease, patient-centered strategy could reduce new human immunodeficiency virus (HIV) …

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy

MR Kamya, H Mayanja-Kizza, A Kambugu… - JAIDS Journal of …, 2007 - journals.lww.com
Background: HIV RNA viral load testing is costly and is generally unavailable in resource-limited
settings. We identified predictors of viral failure and documented genotypic mutations in …

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy

…, EN Janoff, AR Ronald, MR Kamya… - Clinical infectious …, 2008 - academic.oup.com
Background . Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of
persons with acquired immunodeficiency syndrome in Africa. Methods . Two prospective, …

Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start HIV …

…, AM Elbireer, A Kambugu, MR Kamya… - Clinical infectious …, 2010 - academic.oup.com
Background. Cryptococcal meningitis (CM) remains a common AIDS-defining illness in Africa
and Asia. Subclinical cryptococcal antigenemia is frequently unmasked with antiretroviral …

Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts

…, F Wabwire-Mangen, A Talisuna, G Dorsey, MR Kamya… - Acta tropica, 2012 - Elsevier
Malaria remains one of the leading health problems of the developing world, and Uganda
bears a particularly large burden from the disease. Our understanding is limited by a lack of …

[HTML][HTML] Dihydroartemisinin–piperaquine for the prevention of malaria in pregnancy

…, A Muehlenbachs, DV Havlir, MR Kamya… - … England Journal of …, 2016 - Mass Medical Soc
Background Intermittent treatment with sulfadoxine–pyrimethamine is widely recommended
for the prevention of malaria in pregnant women in Africa. However, with the spread of …

Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial

…, C Maiteki-Sebuguzi, C Dokomajilar, MR Kamya… - Jama, 2007 - jamanetwork.com
ContextCombination therapy is now widely advocated as first-line treatment for uncomplicated
malaria in Africa. However, it is not clear which treatment regimens are optimal or how to …

Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 Genes and Clinical Response to Chloroquine in Kampala, Uganda

G Dorsey, MR Kamya, A Singh… - The Journal of …, 2001 - academic.oup.com
The molecular mechanism of chloroquine resistance in Plasmodium falciparum remains
uncertain. Polymorphisms in the pfcrt and pfmdr-1 genes have been associated with …

[HTML][HTML] Evolution of partial resistance to artemisinins in malaria parasites in Uganda

…, SL Nsobya, RA Cooper, MR Kamya… - … England Journal of …, 2023 - Mass Medical Soc
Background Partial resistance of Plasmodium falciparum to the artemisinin component of
artemisinin-based combination therapies, the most important malaria drugs, emerged in …

[HTML][HTML] Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional …

…, B Kirenga, N Chavannes, M Kamya… - The Lancet Global …, 2015 - thelancet.com
Background In sub-Saharan Africa, little is known about the damage to respiratory health
caused by biomass smoke and tobacco smoke. We assessed the prevalence of chronic …